Adicet Bio Inc. (ACET) NASDAQ

$2.33 0.09 (4.02%)

Market Cap: $193.06M

As of 03/28/24 04:00 PM EDT. Market closed.

(ACET)

Adicet Bio Inc. (ACET)
NASDAQ

$2.33
0.09 (4.02%)

Market Cap: $193.06M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

adicet bio, inc. is a privately held, pre-clinical stage biotechnology company engaged in the design and development of cutting-edge immunotherapies with initial focus on cancer. adicet is developing novel universal immune cell therapies based on gamma delta t cells engineered with chimeric antigen receptors (cars) or t cell receptors (tcrs). adicet is also focused on identifying and validating ... read more

adicet bio, inc. is a privately held, pre-clinical stage biotechnology company engaged in the design and development of cutting-edge immunotherapies with initial focus on cancer. adicet is developing novel universal immune cell therapies based on gamma delta t cells engineered with chimeric antigen receptors (cars) or t cell receptors (tcrs). adicet is also focused on identifying and validating cancer specific targets directed to the intracellular proteome and generating tcr-like mabs (tcrls) directed to these cancer-specific peptide targets presented by mhc class i complexes. these tcrls can be used to arm t cells, as t cell engagers or as antibody drug conjugates (adc). in august 2016, adicet entered a strategic collaboration with regeneron pharmaceuticals, inc. to develop next-generation engineered immune-cell therapeutics using adicet’s gamma delta t cell allogeneic platform technology. adicet bio raised $51m in series a financing led by orbimed partners, orbimed israel, novartis v read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO Compensation (Base)
$619,914
CEO Compensation (Total)
$2.28M
URL
Address
500 Boylston St Fl 12, Massachusetts, Boston, 02116-3740.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
Chen Schor
CEO Compensation (Base)
$619,914
CEO Compensation (Total)
$2.28M
Address
500 Boylston St Fl 12, Massachusetts, Boston, 02116-3740.
PRICE CHART FOR ADICET BIO INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.36
Previous Close
$2.24
Days Range
$2.21 - $2.34
52 week range
$1.10 - $7.50
Volume
534,078
Avg. Volume (30 days)
1,530,059
Market Cap
$193.06M
Dividend Yield
-
P/E
-
Shares Outstanding
82,153,984
Open
$2.36
Previous Close
$2.24
Days Range
$2.21 - $2.34
52 week range
$1.10 - $7.50
Volume
534,078
Avg. Volume (30 days)
1,530,059
Market Cap
$193.06M
Dividend Yield
-
P/E
-
Shares Outstanding
82,153,984
FINANCIAL STATEMENTS FOR ADICET BIO INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ADICET BIO INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
ORBIMED ADVISORS LLCDirectorJan 25, 2024 Buy$2.403,125,0007,500,0007,526,359Jan 26, 2024, 07:14 PM
GORDON CARL LDirectorJan 25, 2024 Buy$2.403,125,0007,500,0007,526,359Jan 26, 2024, 07:13 PM
Galimi FrancescoSVP & Chief Medical OfficerJan 24, 2024 Option Exercise$2.404,95711,89775,501Jan 26, 2024, 07:11 PM
Aftab BlakeChief Scientific OfficerJan 24, 2024 Option Exercise$2.403,5658,55642,811Jan 26, 2024, 07:10 PM
Healey DonChief Technology OfficerJan 24, 2024 Option Exercise$2.404,87011,68852,629Jan 26, 2024, 07:09 PM
Harvey Brian NicholasChief Financial OfficerJan 24, 2024 Option Exercise$2.404,32010,36873,500Jan 26, 2024, 07:08 PM
Schor ChenPresident & CEOJan 24, 2024 Option Exercise$2.4015,29036,696138,471Jan 26, 2024, 07:06 PM
Aftab BlakeChief Scientific OfficerOct 12, 2023 Option Exercise$1.357,93310,71046,376Oct 16, 2023, 04:11 PM
Galimi FrancescoSVP & Chief Medical OfficerOct 02, 2023 Option Exercise$1.378,09311,08780,458Oct 03, 2023, 04:24 PM
Healey DonChief Technology OfficerOct 02, 2023 Option Exercise$1.379,06912,42557,499Oct 03, 2023, 04:22 PM
Schor ChenPresident & CEOOct 02, 2023 Option Exercise$1.3723,20831,795153,761Oct 02, 2023, 08:16 PM
Schor ChenPresident & CEOSep 28, 2023 Buy$1.425,5007,810182,469Oct 02, 2023, 08:16 PM
Schor ChenPresident & CEOOct 02, 2023 Buy$1.335,5007,34043,469Oct 02, 2023, 08:16 PM
Schor ChenPresident & CEOSep 29, 2023 Sale$1.365,5007,481176,969Oct 02, 2023, 08:16 PM
Schor ChenPresident & CEOSep 28, 2023 Sale$1.425,5007,81037,969Oct 02, 2023, 08:16 PM
DUBIN STEVEDirectorJun 30, 2023 Buy$2.405,00011,99910,900Jun 30, 2023, 04:08 PM
GORDON CARL LDirectorJun 27, 2023 Buy$2.09875,0001,828,7505,685,259Jun 29, 2023, 04:51 PM
ORBIMED ADVISORS LLCDirectorJun 27, 2023 Buy$2.09875,0001,828,7505,685,259Jun 29, 2023, 04:46 PM
Healey DonChief Technology OfficerFeb 15, 2023 Sale$7.574,53334,32766,568Feb 17, 2023, 08:22 PM
Healey DonChief Technology OfficerFeb 10, 2023 Sale$7.9810,46783,47671,101Feb 14, 2023, 04:50 PM
Aftab BlakeChief Scientific OfficerNov 10, 2022 Sale$21.006,967146,30728,209Nov 15, 2022, 04:32 PM
Schor ChenPresident & CEONov 10, 2022 Sale$20.0630,000601,92053,424Nov 15, 2022, 04:31 PM
Schor ChenPresident & CEONov 10, 2022 Sale$21.039,955209,32291,469Nov 15, 2022, 04:31 PM
Schor ChenPresident & CEONov 07, 2022 Sale$19.0530,000571,48883,424Nov 09, 2022, 04:05 PM
Schor ChenPresident & CEONov 02, 2022 Sale$18.005009,000138,237Nov 04, 2022, 05:23 PM
Schor ChenPresident & CEONov 03, 2022 Sale$18.0424,813447,718113,424Nov 04, 2022, 05:23 PM
Aftab BlakeChief Scientific OfficerOct 19, 2022 Sale$16.278,067131,25035,176Oct 21, 2022, 04:10 PM
Aftab BlakeChief Scientific OfficerOct 13, 2022 Option Exercise$15.927,933126,29343,243Oct 14, 2022, 04:08 PM
Aftab BlakeChief Scientific OfficerOct 12, 2022 Option Exercise$7.383,38825,00352,822Oct 14, 2022, 04:08 PM
Aftab BlakeChief Scientific OfficerOct 12, 2022 Sale$15.401,64625,34851,176Oct 14, 2022, 04:08 PM
Schor ChenPresident & CEOOct 04, 2022 Option Exercise$14.2221,288302,715101,424Oct 04, 2022, 05:22 PM
Harvey Brian NicholasChief Financial OfficerOct 04, 2022 Option Exercise$14.227,096100,90558,816Oct 04, 2022, 05:21 PM
Healey DonChief Technology OfficerOct 04, 2022 Option Exercise$14.227,933112,80755,468Oct 04, 2022, 05:20 PM
Galimi FrancescoSVP & Chief Medical OfficerOct 04, 2022 Option Exercise$14.227,933112,80762,451Oct 04, 2022, 05:18 PM
Schor ChenPresident & CEOSep 14, 2022 Sale$18.0095217,136138,737Sep 16, 2022, 05:51 PM
Schor ChenPresident & CEOSep 13, 2022 Sale$18.013,37160,713139,689Sep 13, 2022, 04:59 PM
Schor ChenPresident & CEOSep 12, 2022 Sale$16.7766,9471,122,907143,060Sep 13, 2022, 04:59 PM
Schor ChenPresident & CEOSep 09, 2022 Sale$16.518,094133,60166,747Sep 13, 2022, 04:59 PM
Schor ChenPresident & CEOAug 04, 2022 Option Exercise$18.2521,288388,506122,712Aug 08, 2022, 08:32 PM
Galimi FrancescoSVP & Chief Medical OfficerAug 04, 2022 Option Exercise$18.255,533100,97770,384Aug 08, 2022, 08:31 PM
Aftab BlakeChief Scientific OfficerAug 04, 2022 Option Exercise$18.255,533100,97749,434Aug 08, 2022, 08:29 PM
Harvey Brian NicholasChief Financial OfficerAug 04, 2022 Option Exercise$18.254,69685,70265,912Aug 08, 2022, 08:27 PM
Healey DonChief Technology OfficerAug 04, 2022 Option Exercise$18.255,533100,97763,401Aug 08, 2022, 08:26 PM
Aftab BlakeChief Scientific OfficerAug 03, 2022 Sale$18.006,968125,42438,967Aug 05, 2022, 06:43 PM
Aftab BlakeChief Scientific OfficerAug 01, 2022 Sale$16.646,968115,94845,935Aug 03, 2022, 04:16 PM
Aftab BlakeChief Scientific OfficerJul 05, 2022 Sale$14.501,36319,76452,903Jul 07, 2022, 05:12 PM
Galimi FrancescoSVP & Chief Medical OfficerApr 04, 2022 Option Exercise$13.917,979110,95665,953Apr 05, 2022, 06:23 PM
Galimi FrancescoSVP & Chief Medical OfficerApr 01, 2022 Option Exercise$5.977,62145,49767,538Apr 05, 2022, 06:23 PM
Galimi FrancescoSVP & Chief Medical OfficerApr 04, 2022 Sale$21.007,979167,55959,917Apr 05, 2022, 06:23 PM
Galimi FrancescoSVP & Chief Medical OfficerApr 01, 2022 Sale$21.007,621160,04159,917Apr 05, 2022, 06:23 PM
Jakobovits AyaDirectorMar 09, 2022 Sale$14.004,00056,000356,345Mar 11, 2022, 04:08 PM
Jakobovits AyaDirectorFeb 16, 2022 Sale$14.834,00059,328358,345Feb 17, 2022, 06:10 PM
Healey DonChief Technology OfficerFeb 14, 2022 Option Exercise$14.275,53378,95652,934Feb 16, 2022, 09:41 PM
Aftab BlakeChief Scientific OfficerFeb 14, 2022 Option Exercise$14.275,53378,95652,903Feb 16, 2022, 09:40 PM
Galimi FrancescoSVP & Chief Medical OfficerFeb 14, 2022 Option Exercise$14.275,53378,95659,917Feb 16, 2022, 09:36 PM
Harvey Brian NicholasChief Financial OfficerFeb 14, 2022 Option Exercise$14.274,69667,01254,608Feb 16, 2022, 09:33 PM
Schor ChenPresident & CEOFeb 14, 2022 Option Exercise$14.2721,288303,780149,424Feb 16, 2022, 09:31 PM
Galimi FrancescoSVP & Chief Medical OfficerJan 28, 2022 Option Exercise$11.695,53364,68149,450Feb 01, 2022, 08:50 PM
Healey DonChief Technology OfficerJan 28, 2022 Option Exercise$11.695,53364,68142,467Feb 01, 2022, 08:48 PM
Aftab BlakeChief Scientific OfficerJan 28, 2022 Option Exercise$11.695,56465,04342,436Feb 01, 2022, 08:44 PM
Harvey Brian NicholasChief Financial OfficerJan 28, 2022 Option Exercise$11.694,69654,89643,304Feb 01, 2022, 08:42 PM
Schor ChenPresident & CEOJan 28, 2022 Option Exercise$11.6921,288248,857122,712Feb 01, 2022, 08:40 PM
GORDON CARL LDirectorDec 10, 2021 Option Exercise$14.00214,2852,999,990242,285Dec 14, 2021, 07:06 PM
ORBIMED ADVISORS LLCDirectorDec 10, 2021 Option Exercise$14.00214,2852,999,990242,285Dec 14, 2021, 06:41 PM
Sinclair AndrewDirectorDec 08, 2021 Buy$14.00500,0007,000,0002,115,385Dec 13, 2021, 06:00 PM
Sinclair AndrewDirectorDec 08, 2021 Buy$14.00500,0007,000,0002,140,721Dec 10, 2021, 05:30 PM
Schor ChenPresident & CEOJun 16, 2021 Sale$10.5316,466173,44389,836Jun 21, 2021, 04:25 PM
Jakobovits AyaDirectorJun 15, 2021 Sale$11.163,84742,919215,883Jun 17, 2021, 06:08 PM
Galimi FrancescoSVP & Chief Medical OfficerJun 04, 2021 Option Exercise$5.976,98341,6896,983Jun 08, 2021, 09:35 PM
Schor ChenPresident & CEOMay 19, 2021 Sale$13.4516,466221,436108,533May 21, 2021, 04:34 PM
Schor ChenPresident and CEOApr 20, 2021 Sale$12.0116,466197,676125,764Apr 22, 2021, 04:34 PM
Schor ChenPresident and CEOApr 06, 2021 Sale$13.0416,466214,700134,746Apr 08, 2021, 04:37 PM
Schor ChenPresident and CEOMar 30, 2021 Sale$12.8516,466211,640149,128Apr 01, 2021, 06:48 PM
Schor ChenPresident and CEOMar 16, 2021 Sale$15.3416,466252,558155,218Apr 01, 2021, 06:43 PM
Schor ChenPresident and CEOMar 16, 2021 Sale$15.3416,466252,558155,218Mar 18, 2021, 09:55 PM
Chimovits ErezDirectorFeb 12, 2021 Option Exercise$13.00524,3496,816,5375,243,259Feb 18, 2021, 09:44 PM
GORDON CARL LDirectorFeb 12, 2021 Option Exercise$13.00524,3496,816,5375,243,259Feb 18, 2021, 09:41 PM
ORBIMED ADVISORS LLCDirectorFeb 12, 2021 Option Exercise$13.00524,3496,816,5375,243,259Feb 18, 2021, 09:38 PM
PureTech Health LLC10% OwnerDec 18, 2019 Sale$1.206,161,5317,393,8372,119,696Dec 19, 2019, 05:26 PM
PureTech Health LLC10% OwnerDec 13, 2019 Sale$1.24205,763255,8058,281,227Dec 17, 2019, 06:27 PM
PureTech Health LLC10% OwnerDec 12, 2019 Sale$1.25385,884482,3168,486,990Dec 12, 2019, 05:59 PM
PureTech Health LLC10% OwnerDec 11, 2019 Sale$1.2559,92174,9018,872,874Dec 12, 2019, 05:59 PM
PureTech Health LLC10% OwnerDec 10, 2019 Sale$1.26336,561423,6638,932,795Dec 12, 2019, 05:59 PM
PureTech Health LLC10% OwnerNov 15, 2019 Sale$1.25531,040661,9419,269,356Nov 19, 2019, 04:25 PM
Schor ChenPresident and CEOApr 16, 2018 Buy$8.952,00017,9071,892,363Apr 17, 2018, 08:08 AM
Schor ChenPresident and CEOApr 11, 2018 Buy$9.362,00018,7241,890,363Apr 12, 2018, 07:32 AM
Schor ChenPresident and CEOApr 10, 2018 Buy$8.462,00016,9151,888,363Apr 11, 2018, 08:06 AM
SILVERSTEIN JONATHANDirectorJan 30, 2018 Buy$15.00533,3337,999,9954,830,387Jan 30, 2018, 06:42 PM
ORBIMED ADVISORS LLCDirectorJan 30, 2018 Buy$15.00533,3337,999,9954,830,387Jan 30, 2018, 06:41 PM
PureTech Health LLC10% OwnerJan 30, 2018 Buy$15.00233,3333,499,9959,800,396Jan 30, 2018, 06:37 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
ORBIMED ADVISORS LLCDirector01/25/20247,500,000
GORDON CARL LDirector01/25/20247,500,000
Galimi FrancescoSVP & Chief Medical Officer01/24/202411,897
Aftab BlakeChief Scientific Officer01/24/20248,556
Healey DonChief Technology Officer01/24/202411,688
Harvey Brian NicholasChief Financial Officer01/24/202410,368
Schor ChenPresident & CEO01/24/202436,696
Aftab BlakeChief Scientific Officer10/12/202310,710
Galimi FrancescoSVP & Chief Medical Officer10/02/202311,087
Healey DonChief Technology Officer10/02/202312,425
Schor ChenPresident & CEO10/02/202331,795
Schor ChenPresident & CEO09/28/20237,810
Schor ChenPresident & CEO10/02/20237,340
Schor ChenPresident & CEO09/29/20237,481
Schor ChenPresident & CEO09/28/20237,810
DUBIN STEVEDirector06/30/202311,999
GORDON CARL LDirector06/27/20231,828,750
ORBIMED ADVISORS LLCDirector06/27/20231,828,750
Healey DonChief Technology Officer02/15/202334,327
Healey DonChief Technology Officer02/10/202383,476
Aftab BlakeChief Scientific Officer11/10/2022146,307
Schor ChenPresident & CEO11/10/2022601,920
Schor ChenPresident & CEO11/10/2022209,322
Schor ChenPresident & CEO11/07/2022571,488
Schor ChenPresident & CEO11/02/20229,000
Schor ChenPresident & CEO11/03/2022447,718
Aftab BlakeChief Scientific Officer10/19/2022131,250
Aftab BlakeChief Scientific Officer10/13/2022126,293
Aftab BlakeChief Scientific Officer10/12/202225,003
Aftab BlakeChief Scientific Officer10/12/202225,348
Schor ChenPresident & CEO10/04/2022302,715
Harvey Brian NicholasChief Financial Officer10/04/2022100,905
Healey DonChief Technology Officer10/04/2022112,807
Galimi FrancescoSVP & Chief Medical Officer10/04/2022112,807
Schor ChenPresident & CEO09/14/202217,136
Schor ChenPresident & CEO09/13/202260,713
Schor ChenPresident & CEO09/12/20221,122,907
Schor ChenPresident & CEO09/09/2022133,601
Schor ChenPresident & CEO08/04/2022388,506
Galimi FrancescoSVP & Chief Medical Officer08/04/2022100,977
Aftab BlakeChief Scientific Officer08/04/2022100,977
Harvey Brian NicholasChief Financial Officer08/04/202285,702
Healey DonChief Technology Officer08/04/2022100,977
Aftab BlakeChief Scientific Officer08/03/2022125,424
Aftab BlakeChief Scientific Officer08/01/2022115,948
Aftab BlakeChief Scientific Officer07/05/202219,764
Galimi FrancescoSVP & Chief Medical Officer04/04/2022110,956
Galimi FrancescoSVP & Chief Medical Officer04/01/202245,497
Galimi FrancescoSVP & Chief Medical Officer04/04/2022167,559
Galimi FrancescoSVP & Chief Medical Officer04/01/2022160,041
Jakobovits AyaDirector03/09/202256,000
Jakobovits AyaDirector02/16/202259,328
Healey DonChief Technology Officer02/14/202278,956
Aftab BlakeChief Scientific Officer02/14/202278,956
Galimi FrancescoSVP & Chief Medical Officer02/14/202278,956
Harvey Brian NicholasChief Financial Officer02/14/202267,012
Schor ChenPresident & CEO02/14/2022303,780
Galimi FrancescoSVP & Chief Medical Officer01/28/202264,681
Healey DonChief Technology Officer01/28/202264,681
Aftab BlakeChief Scientific Officer01/28/202265,043
Harvey Brian NicholasChief Financial Officer01/28/202254,896
Schor ChenPresident & CEO01/28/2022248,857
GORDON CARL LDirector12/10/20212,999,990
ORBIMED ADVISORS LLCDirector12/10/20212,999,990
Sinclair AndrewDirector12/08/20217,000,000
Sinclair AndrewDirector12/08/20217,000,000
Schor ChenPresident & CEO06/16/2021173,443
Jakobovits AyaDirector06/15/202142,919
Galimi FrancescoSVP & Chief Medical Officer06/04/202141,689
Schor ChenPresident & CEO05/19/2021221,436
Schor ChenPresident and CEO04/20/2021197,676
Schor ChenPresident and CEO04/06/2021214,700
Schor ChenPresident and CEO03/30/2021211,640
Schor ChenPresident and CEO03/16/2021252,558
Schor ChenPresident and CEO03/16/2021252,558
Chimovits ErezDirector02/12/20216,816,537
GORDON CARL LDirector02/12/20216,816,537
ORBIMED ADVISORS LLCDirector02/12/20216,816,537
PureTech Health LLC10% Owner12/18/20197,393,837
PureTech Health LLC10% Owner12/13/2019255,805
PureTech Health LLC10% Owner12/12/2019482,316
PureTech Health LLC10% Owner12/11/201974,901
PureTech Health LLC10% Owner12/10/2019423,663
PureTech Health LLC10% Owner11/15/2019661,941
Schor ChenPresident and CEO04/16/201817,907
Schor ChenPresident and CEO04/11/201818,724
Schor ChenPresident and CEO04/10/201816,915
SILVERSTEIN JONATHANDirector01/30/20187,999,995
ORBIMED ADVISORS LLCDirector01/30/20187,999,995
PureTech Health LLC10% Owner01/30/20183,499,995
Load More Insider Transactions
FUNDS WITH A POSITION IN ADICET BIO INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ORBIMED ADVISORS LLC9,772,5980.39%17.43%Other
BlackRock Inc.2,111,8980.00017%-3.24%Other
RENAISSANCE TECHNOLOGIES LLC766,6000.00224%13.23%Other
GEODE CAPITAL MANAGEMENT, LLC661,7950.00013%4.56%Other
D. E. SHAW & CO., INC.346,6190.00057%41.55%Other
AQR CAPITAL MANAGEMENT LLC75,0220.00021%ExitedOther
BALYASNY ASSET MANAGEMENT L.P.12,5500.00004%ExitedEvent Driven
CHANGE IN SHARES OUTSTANDING FOR ADICET BIO INC
STOCK BUYBACKS FOR ADICET BIO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.43%
1Q
12/31/2023
06/30/2023
0.48%
2Q
12/31/2023
03/31/2023
0.48%
3Q
12/31/2023
12/31/2022
1.14%
4Q
12/31/2023
09/30/2022
3.65%
5Q
12/31/2023
06/30/2022
7.71%
6Q
12/31/2023
03/31/2022
-6.08%
7Q
12/31/2023
12/31/2021
27.16%
8Q
12/31/2023
09/30/2021
35.41%
9Q
12/31/2023
06/30/2021
35.63%
10Q
12/31/2023
03/31/2021
65.38%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.43%
1Q
06/30/2023
0.48%
2Q
03/31/2023
0.48%
3Q
12/31/2022
1.14%
4Q
09/30/2022
3.65%
5Q
06/30/2022
7.71%
6Q
03/31/2022
-6.08%
7Q
12/31/2021
27.16%
8Q
09/30/2021
35.41%
9Q
06/30/2021
35.63%
10Q
03/31/2021
65.38%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ADICET BIO INC
LOADING...